Direct reprogramming of one cell type into another has recently emerged as a powerful paradigm for regenerative medicine, disease modeling, and lineage specification. In particular, the conversion of fibroblasts into induced cardiomyocyte-like myocytes (iCLMs) by Gata4, Hand2, Mef2c, and Tbx5 (GHMT) represents an important avenue for generating de novo cardiac myocytes in vitro and in vivo. Recent evidence suggests that GHMT generates a greater diversity of cardiac subtypes than previously appreciated, thus underscoring the need for a systematic approach to conducting additional studies. Before direct reprogramming can be used as a therapeutic strategy, however, the mechanistic underpinnings of lineage conversion must be understood in detail to generate specific cardiac subtypes. Here we present a detailed protocol for generating iCLMs by GHMT-mediated reprogramming of mouse embryonic fibroblasts (MEFs).
Introduction
The heart is the first functional organ to develop in the embryo 1, 2 . In conjunction with the circulatory system, it supplies oxygen, nutrients, and a waste disposal mechanism during development. Three weeks after fertilization, the human heart beats for the first time and its proper regulation is maintained by cardiomyocytes (CMs). The irreversible loss of these specialized cells is therefore the fundamental issue underlying progressive heart failure. While some organisms such as the zebrafish and Xenopus have the potential for cardiac regeneration, the adult mammalian heart is more limited 3, 5, 6 . Thus, given the critical function of the heart, it is not astonishing that heart disease is the leading cause of death in the world, accounting for 600,000 deaths in the United States alone 7 . Therefore, cell-based therapies to efficiently repair or replace the injured myocardium are of great clinical interest.
The seminal study of Yamanaka and colleagues 8 showed that forced expression of four transcription factors is sufficient to convert fully differentiated fibroblast cells to pluripotent stem cells. However, the tumorigenic capacity of all pluripotent stem cell strategies has been a critical concern in their use for therapeutic purposes. This motivated the scientific field to search for alternative methods to transdifferentiate cells while avoiding a pluripotent stage. Recently, several groups have shown the feasibility of this strategy by displaying direct conversion of mouse fibroblasts to induced cardiomyocyte-like cells (iCLMs) with the ectopic expression of the transcription factors Gata4, Mef2c, Tbx5, and later on, Hand2 (GMT and GHMT, respectively) 9, 10 . Furthermore, the same strategy can be performed in vivo and in human-derived tissues 9, 11, 12 . Recent studies have highlighted additional factors or signaling pathways that can be modulated to further improve cardiac reprogramming efficiency 13, 14, 15 . Taken together, these studies demonstrate the potential of directed transdifferentiation for regenerative therapies. However, the low efficiency of CM reprogramming, the unknown molecular mechanisms, inconsistent reproducibility due to methodological differences 16 , and the heterogeneous nature of iCLMs remain unaddressed.
In order to directly evaluate iCLM heterogeneity, we designed a discrete and robust single-cell assay for the identification of sarcomere development and cardiac lineage specification-two necessary characteristics of functional cardiomyocytes. There are at least three major types of CM in the heart as defined by their location and unique electrical properties: atrial (AM), ventricular (VM) and pacemaker (PM) Over-digestion of the tissue will significantly lower the yield.
8. Vortex cell mixture at maximum speed (3,200 rpm) for 4 s. 9. Add 2 mL of fibroblast media per embryo and mix. Filter through a 100 µm cell strainer using a pipette to aid the cells through the strainer. Refer to Table 1 for the formulation of all subsequent mediums. 10. Spin at 300 x g for 4 min. Carefully aspirate supernatant. 11. Add 10 mL of fresh fibroblast media per 3 embryos and triturate 6-10 times. 12. Plate the cells in 1 15-cm tissue culture dish for every 3 embryos prepared. Culture overnight in a 37 °C, 5% CO 2 incubator. 13. After the overnight incubation, replace the media with fresh 30 mL of media per plate. Place cells back into the incubator overnight.
NOTE: Check for Hcn4-GFP + cell contamination under a fluorescent microscope. The culture should be GFP -and only become GFP + upon reprogramming. 14. The next day, harvest cells with 3 mL of fresh pre-warmed 0.25% trypsin-EDTA. Count and freeze cells. Typically, freeze cells at 3 x 10 6 cells per mL. The expected yield should be 3 x 10 6 cells per embryo.
Retrovirus Production and Reprogramming
Caution: The following protocol requires production and handling of infectious retroviruses. Perform the following steps in a Biosafety Level 2 cabinet under BSL-2 guidelines and sterile technique. Use 10% bleach to dispose of all materials exposed to retroviruses.
1. Retrovirus production and MEFs preparation NOTE: The following protocol is for retroviral production in 6-well plates and MEF infection in 24-well plates. For other formats, refer to Table  2 . MEFs are plated at Day -1, so the timing will need to be coordinated appropriately for each experiment (Refer to section 2.3 and Figure 2 Although the titer is not directly measured for each experiment, a GFP control is always included as a surrogate for infection efficiency. High GFP expression and intensity (GFP + > 95%) typically correlates with successful GHMT-mediated generation of iCLMs.
1. Day 0: 24 h post-transfection, filter the PE retroviral medium through a 0.45 µm-pore size surfactant-free cellulose acetate filter and transfer to a 15 mL conical tube. Add polybrene to a final concentration of 8 µg/mL. Carefully replenish cells with 2 mL of fresh transfection medium. NOTE: Cells easily detach from the plate if media is changed too rapidly. 2. Aspirate the medium of the cultured MEFs and add the freshly collected retroviral medium; it should yield 1.7 mL of media per well of a 6-well plate. Add ~800 µL per well of a 24-well plate. Return MEF plate to the incubator and incubate overnight. 9. Wash wells x3 with 300 µL 0.1% PBST. Incubate 5 min at RT between washes. Protect from light. 10. Add 2.4 µL of mounting media containing 1.5 µg/mL of 4',6-diamidino-2-phenylindole (DAPI) to a glass microscope slide. Carefully remove the coverslip from the well of the 24-well plate, remove excess solution, and transfer to the glass slide with mounting media. Gently press the coverslip to remove excess volume and air. 11. Seal slides with preferred nail polish or plastic sealant. Store mounted slides at 4 °C protected from light.
Immunostaining of Reprogrammed MEFs

Identification of Cardiac Subtypes Using Confocal Microscopy
NOTE: For imaging, a confocal microscope equipped with at least 2 fluorescent detectors capable of spectral detection at 405, 488, 555, and 639 nm wavelengths is necessary in order to identify iPMs, iAMs, and iVMs. Image cells using a Plan-Apochromat 20X/0.75 objective or better. Using the manufacturer's image analysis software, scanning zoom images can achieve 40X-oil immersion quality images. 
Quantification
NOTE: In order to assess the actual number of potentially reprogrammed MEFs, 2 wells of a 24-well plate are seeded in parallel to the experimental wells and are harvested one day after plating. The total number of cells plated is then determined by averaging the two wells. This becomes the actual total cells plated (aTotal). 
Representative Results
Taking advantage of the PM-specific reporter mouse, we developed a multiplex immunostaining strategy to identify diverse endogenous myocytes as depicted in 
Discussion
The present study provides a direct-reprogramming strategy for conversion of MEFs into a diverse set of cardiac subtypes via retrovirusmediated expression of the cardiac transcription factors Gata4, Mef2c, Tbx5, and Hand2 (GHMT). Using a multiplex immunostaining approach in combination with a PM-specific reporter mouse, we are able to identify iAM, iVMs, and iPMs at single cell resolution. Such an assay allows for an experimental in vitro system capable of isolating the contributions of individual transcription factors towards subtype diversity and sarcomere development. In parallel, this could bring insight to new transcription factors or small molecules that bias iCLMs towards a particular lineage. Nevertheless, there are several critical steps for the successful completion of this assay. Below, we address the impact of viral titer, fibroblast quality, and imaging analysis in a general iCLM experiment.
In our study, we employ ecotropic-retroviruses to reprogram E12.5 MEFs. We noticed the retroviral titer is directly related to the quality of the cells. High passage number (> 35) and poor culturing techniques severely affect the quality of the retroviral particles; therefore, there are several considerations to keep in mind. Plat-E cells do not produce VSV-G pseudotyped virus, and are thus unable to withstand ultracentrifugation or freezing cycles 24, 25 . In order to preserve the longevity of the cells, it is imperative to maintain the stock with antibiotic selection. However, they should be maintained in antibiotic free media during viral production. In our experience, the transfection reagent used here provides the highest transfection efficiencies in cells. If other transfection methods are to be used, comparing the viral titers produced is essential 26 . Although there are recommendations by the manufacturer to harvest the viral supernatant 48 h after transfection, we observed that two 24-h harvesting rounds yield higher reprogramming efficiencies while avoiding toxic effects usually associated with higher-titer viral preps. Furthermore, though several studies have shown the feasibility of commercial viral supernatant concentrators 27 , we have not employed these in our regular protocol in order to maintain a higher throughput.
In addition to high titer viral cocktails, fibroblast quality is of crucial importance for a successful reprogramming assay 28 . If timed correctly, freshly isolated MEFs should be utilized due to their higher efficiencies compared to frozen stocks. This could be related to the nature of retroviruses, as they need a highly-proliferative host in order to integrate 29 . Additionally, MEF seeding density plays a critical role. We have included a table with the seeding densities employed in our experiments ( Table 2) . Moreover, passaging the MEFs will also significantly decrease reprogramming efficiency.
Immunocytochemistry (ICC) is our standard technique for analysis of sarcomere organization and subtype specification. With the help of a PM-GFP reporter mouse, we were able to form an antibody panel for the detection of three major cardiac subtypes (AM, VM, and PM). However, due to constraints of antibody species availability and the limitation of 4-channels on a standard confocal microscope set-up, two coverslips per subtype are needed to quantify the prevalence of all three subtypes. One coverslip will stain for α-Actinin/GFP(Hcn4)/Myl2, and one for α-Actinin/GFP(Hcn4)/Nppa. Based on our previous observation that sarcomeric structure is a common characteristic of all CMs and a potential prerequisite for subtype specification 21 , the first step in our analysis is determining sarcomere + cells. Yet, due to its subjective nature, establishing the level of sarcomere organization is perhaps the most difficult part of this assay; this can be limited by averaging multiple observer's quantifications or by developing computational cell segmentation software to automate the process 30 . Using endogenous cells as a point of reference, we discovered a threshold for well-organized sarcomere + and utilized that to score iCLMs (Figure 3 ). Given these parameters, an average experiment will give rise to 20 -30% α-Actinin + cells but only 1% are α-Actinin Given that cardiomyocytes are structurally complex, population-based gene expression (e.g. qRT-PCR) or flow cytometry analyses cannot capture the intricate morphological changes that occur during iCLM reprogramming. In contrast, patch clamping and calcium transient imaging are highly stringent single-cell functional assays, but specialized skills and equipment are required to conduct these experiments. Thus, the described methodology is unique in that it provides a straightforward approach to study key structural and functional parameters of iCLM reprogramming without significantly compromising throughput.
Despite the many recent advances in direct reprogramming, much work remains to be done to better understand the molecular mechanisms that regulates cardiac reprogramming, and more specifically, subtype specification. These mechanisms will become especially important to translate direct reprogramming for clinical applications. As such, in this study we describe a platform capable of directly modulating discrete parameters to assess the contribution towards sarcomere development, subtype specification, and iCLM maturity. Moreover, this system can be further developed to work in a high-throughput format allowing for complex screening of small molecules or extracellular matrixes for the next step in regenerative cardiology.
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